Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local injection of Xiapex for refractory gastrointestinal strictures
2018-003637-14Phase 2Terminated
- Sponsor
- Ghent University Hospital
- Start
- Jan 2019
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of collagenase clostridium histolyticum in Gastrointestinal stricture and gastrointestinal anastomotic stricture (2 arms), sponsored by Ghent University Hospital. Primary endpoint: Number of repeat dilations over 6 months. Started Jan 2019; status: terminated.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Gastrointestinal stricturegastrointestinal anastomotic stricture
Beyond the preview
Go deeper on 2018-003637-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003637-14.